Edition:
United States

BioDelivery Sciences International Inc (BDSI.OQ)

BDSI.OQ on NASDAQ Stock Exchange Capital Market

2.80USD
4:00pm EDT
Change (% chg)

$0.10 (+3.70%)
Prev Close
$2.70
Open
$2.70
Day's High
$2.80
Day's Low
$2.65
Volume
27,364
Avg. Vol
78,996
52-wk High
$3.60
52-wk Low
$1.55

Latest Key Developments (Source: Significant Developments)

BioDelivery Sciences CEO Mark Sirgo to retire
Wednesday, 23 Aug 2017 07:30am EDT 

Aug 23 (Reuters) - BioDelivery Sciences International Inc :BioDelivery Sciences president and chief executive officer Mark Sirgo to retire at year-end while continuing as vice chairman.Says CEO and president Mark Sirgo to retire.Says ‍Sirgo and board will work together during coming months to determine his successor​.  Full Article

BioDelivery Sciences reports Q2 loss per share $0.27
Wednesday, 9 Aug 2017 04:01pm EDT 

Aug 10 (Reuters) - BioDelivery Sciences International Inc -:BioDelivery Sciences reports second quarter 2017 financial results and provides corporate update.Q2 loss per share $0.27.Q2 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S.Says ‍net revenue for Q2 ended June 30, 2017, was approximately $8.7 million compared to $29.5 million in Q1​.Q2 revenue view $8.4 million -- Thomson Reuters I/B/E/S.  Full Article

Biodelivery Sciences signs agreement with Purdue Pharma
Wednesday, 12 Jul 2017 07:30am EDT 

July 12 (Reuters) - Biodelivery Sciences International Inc :Biodelivery Sciences signs exclusive agreement with Purdue Pharma (Canada) for the licensing and distribution rights of Belbuca in Canada.‍Have signed an exclusive agreement for licensing, distribution, marketing and sale of Belbuca in Canada​.Co eligible to receive upfront, potential milestones of up to $4.5 million cad as well as royalties on sales of Belbuca​.  Full Article

Biodelivery Sciences announces Health Canada approval of Belbuca
Friday, 23 Jun 2017 07:00am EDT 

June 23 (Reuters) - Biodelivery Sciences International Inc :Biodelivery Sciences announces Health Canada approval of Belbuca®.Biodelivery Sciences International Inc says Belbuca is expected to be launched in Canada in early 2018.  Full Article

BioDelivery Sciences announces agreement with CVS/Caremark for Belbuca, Bunavail
Wednesday, 21 Jun 2017 08:48am EDT 

June 21 (Reuters) - BioDelivery Sciences International Inc ::BioDelivery Sciences announces agreement with CVS/Caremark for Belbuca® and Bunavail® through 2020.BioDelivery Sciences International - signed agreement with CVS/Caremark extending access to Belbuca Buccal film and Bunavail Buccal film through 2020.  Full Article

Biodelivery Sciences Q1 earnings per share $0.87
Monday, 15 May 2017 04:01pm EDT 

May 15 (Reuters) - Biodelivery Sciences International Inc :Biodelivery Sciences International Inc - net revenue for Q1 ended March 31, 2017, was approximately $29.5 million..Biodelivery Sciences reports first quarter 2017 financial results and provides corporate update.Q1 earnings per share $0.87.Q1 earnings per share view $0.12 -- Thomson Reuters I/B/E/S.  Full Article

Biodelivery Sciences International files for non-timely 10-Q - SEC Filing
Wednesday, 10 May 2017 05:58pm EDT 

May 10 (Reuters) - Biodelivery Sciences International Inc :Files for non-timely 10-Q - SEC Filing.Biodelivery Sciences International Inc says requires up to five additional days to file form 10-Q for the fiscal quarter ended March 31, 2017.Biodelivery Sciences International says expects to report material increases in product sales revenue, total revenue, operating income and net income in march quarter.  Full Article

Biodelivery Sciences secures debt financing with CRG
Thursday, 23 Feb 2017 07:30am EST 

Biodelivery Sciences International Inc : Biodelivery Sciences secures debt financing with CRG . Biodelivery Sciences International - entered into a senior credit facility with affiliates of CRG LP to retire existing credit facility .Says new credit facility consists of $45 million to be drawn at closing.  Full Article

Stonepine Capital Management reports a 6 pct passive stake in Biodelivery Sciences International as of Jan 3, 2017
Friday, 13 Jan 2017 03:39pm EST 

Stonepine Capital Management LLC:Stonepine Capital Management LLC reports a 6 percent passive stake in Biodelivery Sciences International Inc as of Jan 3, 2017 - SEC filing.  Full Article

BioDelivery Sciences International closed on deals contemplated by termination agreement
Monday, 9 Jan 2017 04:42pm EST 

Biodelivery Sciences International Inc :Biodelivery sciences international-closed on deals contemplated by termination agreement, dated dec. 7, 2016 by and between co, its units - sec filing.  Full Article

BRIEF-BioDelivery Sciences CEO Mark Sirgo to retire

* BioDelivery Sciences president and chief executive officer Mark Sirgo to retire at year-end while continuing as vice chairman